Report : North America Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Neurothrombectomy Devices, Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices); Application (Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas, and Other Applications); End User (Hospitals, Ambulatory Surgical Centers, and Specialized Clinics) and Country
Aneurysm coiling & embolization devices segment by product is estimated to lead the market growth during the forecast period
According to a new market research study of “North America Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Analysis by Product, Application, and End User,” The North America neurovascular devices market is expected to reach US$ 1389.28 Mn in 2027 from US$ 1,004.75 Mn in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020-2027. The report highlights trends prevailing in the North America Neurovascular Devices Market instruments market and the factors driving market along with those that act as hindrances.
The North America neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is expected to register the highest CAGR in the market during the forecast period.
Neurovascular devices are used for the treatment of neurovascular diseases that possibly affects the network of blood vessels that surround the brain. This leads to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems. The prevalence of cerebral aneurysms has increased tremendously across the globe. Nearly, 30,000 people in the United States suffer from brain aneurysm rupture every year. A brain aneurysm ruptures every 18 minutes. The annual rate of rupture in the United States is found close to 8 to 10 per 100,000 people. Thus, it is estimated that the rising prevalence of cerebral aneurysms is likely to fuel the growth of the market during the forecast period.
Key factors that are driving growth of the North America Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.
Penumbra, Inc.; Stryker Corporation; and Medtronic plc are among the leading companies operating in the North America Neurovascular Devices market.
North America Neurovascular Devices Market, By Country (% share)
The report segments in North America Neurovascular Devices Market as follows:
- Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction & Aspiration Devices
- Aneurysm Coiling & Embolization Devices
- Embolic Coils
- Bare Detachable Coils
- Coated Detachable Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Balloon Occlusion Devices
- Distal Fillers
- Support Devices
- Cerebral Aneurysms
- Arteriovenous Malformation & Fistulas
- Other Applications
By End User
- Ambulatory Surgical Centers
- Specialized Clinics